Hemodialysis System
- UID
- IMP/MD/2022/000769_9a9d4b09fbf22e301476de23b697ab3b_5606710a0e821b4f592d36c77c875388
- Device class
- Class C
- Brand name
- TherMax
- License holder
- Baxter India Private Limited
- Approving authority
- CDSCO
- Product information
- The PrisMax control unit is intended for: • Continuous Renal Replacement Therapy (TherMax) for patients with acute renal failure and/or fluid overload. • Therapeutic Plasma Exchange (TherMax) therapy for patients with diseases where removal of plasma components is indicated. • Hemoperfusion (TherMax) for patients with conditions where immediate removal of substances by adsorption is indicated. • Extracorporeal CO2 Removal (TherMax) for patients with conditions where extracorporeal elimination of carbon dioxide is indicated. All treatments administered via the PrisMax control unit must be prescribed by a physician.
Hemodialysis System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2022/000769_9a9d4b09fbf22e301476de23b697ab3b_5606710a0e821b4f592d36c77c875388. This device is marketed under the brand name TherMax. The license holder is Baxter India Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.